Rogel Cancer Center: University of Michigan
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
303
Active:18
Completed:159
Trial Phases
6 Phases
Early Phase 1:10
Phase 1:53
Phase 2:131
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (266 trials with phase data)• Click on a phase to view related trials
Phase 2
131 (49.2%)Not Applicable
67 (25.2%)Phase 1
53 (19.9%)Early Phase 1
10 (3.8%)Phase 4
3 (1.1%)Phase 3
2 (0.8%)An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
Not Applicable
Not yet recruiting
- Conditions
- Neuroendocrine Tumor
- Interventions
- Procedure: Computed TomographyDrug: Gallium Ga 68-DOTA-FAPI-04Procedure: Positron Emission Tomography
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT07132645
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Not Applicable
Recruiting
- Conditions
- Oral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8Stage III Lip and Oral Cavity Cancer AJCC v8Stage IVA Lip and Oral Cavity Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Modified Barium SwallowProcedure: Positron Emission TomographyOther: Questionnaire AdministrationRadiation: Radiation TherapyProcedure: Sentinel Lymph Node BiopsyProcedure: Single Photon Emission Computed TomographyRadiation: Technetium Tc 99m-labeled TilmanoceptOther: Technetium Tc-99m Sulfur Colloid
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT07121595
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Recruiting
- Conditions
- Metastatic Castration-Resistant Prostate Carcinoma
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT07096999
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Not Applicable
Not yet recruiting
- Conditions
- Stage III Head and Neck Cutaneous Squamous Cell CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaResectable Head and Neck Squamous Cell CarcinomaStage IV Head and Neck Cutaneous Squamous Cell CarcinomaStage II Head and Neck Cutaneous Squamous Cell Carcinoma
- Interventions
- Procedure: Biopsy ProcedureProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingProcedure: Positron Emission TomographyProcedure: Surgical Procedure
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT07094685
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
Not Applicable
Recruiting
- Conditions
- Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06941324
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 61
- Next
News
No news found